Literature DB >> 9765245

A K+ channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current.

S Kupershmidt1, D J Snyders, A Raes, D M Roden.   

Abstract

We have cloned HERG USO, a C-terminal splice variant of the human ether-à-go-go-related gene (HERG), the gene encoding the rapid component of the delayed rectifier (IKr), from human heart, and we find that its mRNA is approximately 2-fold more abundant than that for HERG1 (the originally described cDNA). After transfection of HERG USO in Ltk- cells, no current was observed. However, coexpression of HERG USO with HERG1 modified IKr by decreasing its amplitude, accelerating its activation, and shifting the voltage dependence of activation 8.8 mV negative. As with HERG USO, HERGDeltaC (a HERG1 construct lacking the C-terminal 462 amino acids) also produced no current in transfected cells. However, IKr was rescued by ligation of 104 amino acids from the C terminus of HERG1 to the C terminus of HERGDeltaC, indicating that the C terminus of HERG1 includes a domain (</=104 amino acids) that is critical for faithful recapitulation of IKr. The lack of this C-terminal domain not only explains the finding that HERG USO does not generate IKr but also indicates a similar mechanism for hitherto-uncharacterized long QT syndrome HERG mutations that disrupt the splice site or the C-terminal. We suggest that the amplitude and gating of cardiac IKr depends on expression of both HERG1 and HERG USO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765245     DOI: 10.1074/jbc.273.42.27231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Impact of recent molecular studies on evaluation of ventricular arrhythmias.

Authors:  D M Roden
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 2.  Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium.

Authors:  J M Nerbonne
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

3.  Functional characterization of the C-terminus of the human ether-à-go-go-related gene K(+) channel (HERG).

Authors:  E Aydar; C Palmer
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

4.  Alternative splicing and polyadenylation contribute to the generation of hERG1 C-terminal isoforms.

Authors:  Qiuming Gong; Matthew R Stump; A Russell Dunn; Vivianne Deng; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

5.  Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels.

Authors:  A P Larsen; B H Bentzen; M Grunnet
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

6.  Domain analysis of Kv6.3, an electrically silent channel.

Authors:  Natacha Ottschytsch; Adam L Raes; Jean-Pierre Timmermans; Dirk J Snyders
Journal:  J Physiol       Date:  2005-08-11       Impact factor: 5.182

7.  Thermodynamic and kinetic properties of amino-terminal and S4-S5 loop HERG channel mutants under steady-state conditions.

Authors:  Carlos Alonso-Ron; Pilar de la Peña; Pablo Miranda; Pedro Domínguez; Francisco Barros
Journal:  Biophys J       Date:  2008-01-25       Impact factor: 4.033

Review 8.  Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

Authors:  Hugues Abriel; Jean-Sébastien Rougier; José Jalife
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

9.  Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles.

Authors:  Kenshi Hayashi; Wen Shuai; Yuichiro Sakamoto; Haruhiro Higashida; Masakazu Yamagishi; Sabina Kupershmidt
Journal:  Heart Rhythm       Date:  2010-03-27       Impact factor: 6.343

10.  HERG1 currents in native K562 leukemic cells.

Authors:  María S Cavarra; Silvana M del Mónaco; Yanina A Assef; Cristina Ibarra; Basilio A Kotsias
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.